BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.
BD Advanced Patient Monitoring is a global leader in advanced monitoring solutions that expands BD’s portfolio of smart connected care solutions with its growing set of leading monitoring technologies, advanced AI-enabled clinical decision tools and robust innovation pipeline. BD Advanced Patient Monitoring’s technologies are often used simultaneously with the BD Alaris Infusion System in the operating room or intensive care units. Furthermore, the combination of BD’s new advanced monitoring and existing infusion platforms enables future innovation opportunities for closed-loop hemodynamic monitoring and IV fluid and medication administration by integrating combined company data sets and interoperability capabilities—read more.
GE HealthCare and DeepHealth, a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet announced a strategic collaboration to further the...
Biegler Medizinelektronik, based in Austria/Europe, has to its credit more than 40 years of research, development and production in the service of medicine. Customers are...
The entire Geistlich product portfolio has been successfully certified according to MDR – well before the official transition period. The pioneer in medical regeneration...
JD Honigberg International Inc., a company based in Chicago USA, representing US manufacturers since 1985 for their international sales has partnered with General Physiot...
Samsung Electronics introduced a new Samsung Health Software Development Kit (SDK) Suite. Designed to better support developers and researchers in creating innovative hea...
BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring. BD Advance...
Public mammography screening provider in Finland mobilizes against osteoporosis The Finnish mammography provider Suomen Radiologikeskus Oy has signed an agreement with...
Apple unveiled breakthrough sleep and hearing health features coming to the Apple Watch and AirPods Pro 2 that further deliver on Apple’s commitment to health with experi...
AbbVie recently announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for the treatment...
A virtual marketplace leading your business into the future
